Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings plc
Your view on IDGXF
Overview
What the company does, where it operates, and who runs it.
About Integrated Diagnostics Holdings plc
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Hend El Sherbini
- Headquarters
- 12 Castle Street, Saint Helier, JE
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Hend El Sherbini
- Headquarters
- 12 Castle Street, Saint Helier, JE
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology.
The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, it operated a network of 452 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Integrated Diagnostics Holdings plc, and the rating behind it. IDGXF last traded at $0.64, 11.2× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Integrated Diagnostics Holdings plc. Starting points for Integrated Diagnostics Holdings plc: P/E 11.2, EPS $2.41, beta 0.27 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Integrated Diagnostics Holdings plc. Integrated Diagnostics Holdings plc does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Integrated Diagnostics Holdings plc. Trailing twelve-month EPS for Integrated Diagnostics Holdings plc stands at $2.41. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Integrated Diagnostics Holdings plc. Integrated Diagnostics Holdings plc has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Integrated Diagnostics Holdings plc valued side by side against its closest peers. Integrated Diagnostics Holdings plc is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Integrated Diagnostics Holdings plc, and how their positions are changing. At a $372.0M market value, institutional positions materially move Integrated Diagnostics Holdings plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Integrated Diagnostics Holdings plc executives and directors. Shares of Integrated Diagnostics Holdings plc have traded between $0.28 and $0.70 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Integrated Diagnostics Holdings plc. Integrated Diagnostics Holdings plc is a $372.0M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Integrated Diagnostics Holdings plc. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Integrated Diagnostics Holdings plc. Coverage tracks Integrated Diagnostics Holdings plc within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.